Oragenics Inc SEC filings OGEN
Oragenics Inc has 1,003 filings in SEC EDGAR's recent list, going back to Jun 20, 2007. Its latest annual report, Form 10-K, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 16, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | May 20, 2026 | — |
| DEF 14A | Proxy statement | May 20, 2026 | May 20, 2026 |
| PRE 14A | Preliminary proxy statement | May 8, 2026 | May 8, 2026 |
| DEFA14A | Additional proxy material | Apr 11, 2025 | — |
| DEF 14A | Proxy statement | Apr 1, 2025 | Apr 1, 2025 |
| PRE 14A | Preliminary proxy statement | Mar 19, 2025 | Mar 19, 2025 |
| DEFA14A | Additional proxy material | Oct 31, 2024 | — |
| DEF 14A | Proxy statement | Oct 31, 2024 | Oct 31, 2024 |
| DEFA14A | Additional proxy material | Nov 16, 2023 | — |
| DEFA14A | Additional proxy material | Nov 2, 2023 | — |
| DEFA14A | Additional proxy material | Oct 30, 2023 | — |
| DEF 14A | Proxy statement | Oct 30, 2023 | Oct 30, 2023 |
| PRE 14A | Preliminary proxy statement | Oct 10, 2023 | Oct 6, 2023 |
| DEF 14A | Proxy statement | Oct 31, 2022 | Oct 31, 2022 |
| PRE 14A | Preliminary proxy statement | Sep 30, 2022 | Sep 30, 2022 |
| DEFA14A | Additional proxy material | Jan 26, 2022 | — |
| DEFA14A | Additional proxy material | Nov 23, 2021 | — |
| DEF 14A | Proxy statement | Oct 13, 2021 | Oct 13, 2021 |
| PRE 14A | Preliminary proxy statement | Sep 24, 2021 | Sep 24, 2021 |
| DEFA14A | Additional proxy material | Aug 12, 2021 | — |
| DEFA14A | Additional proxy material | Jul 1, 2021 | — |
| DEFA14A | Additional proxy material | Jun 14, 2021 | — |
| DEF 14A | Proxy statement | May 24, 2021 | May 24, 2021 |
| PRE 14A | Preliminary proxy statement | May 4, 2021 | May 4, 2021 |
| DEF 14A | Proxy statement | Jul 13, 2020 | Jul 13, 2020 |
| PRE 14A | Preliminary proxy statement | Jun 19, 2020 | Jun 19, 2020 |
| DEF 14A | Proxy statement | May 16, 2019 | Jun 20, 2019 |
| DEF 14A | Proxy statement | May 17, 2018 | Jun 22, 2018 |
| PRE 14A | Preliminary proxy statement | Apr 24, 2018 | Jun 22, 2018 |
| DEF 14C | Information statement | Dec 8, 2017 | Dec 8, 2017 |
| PRE 14C | Filing | Nov 20, 2017 | Nov 20, 2017 |
| DEF 14C | Information statement | Jun 28, 2017 | Jun 28, 2017 |
| PRE 14C | Preliminary info statement | Jun 2, 2017 | Jun 2, 2017 |
| DEF 14A | Proxy statement | Mar 29, 2017 | May 4, 2017 |
| DEF 14C | Information statement | Dec 19, 2016 | Dec 19, 2016 |
| PRE 14C | Preliminary information statement | Dec 2, 2016 | Dec 2, 2016 |
| DEF 14A | Proxy statement | Jul 15, 2016 | Aug 25, 2016 |
| DEF 14C | Information statement | Aug 19, 2015 | Aug 19, 2015 |
| PRE 14C | Preliminary information statement | Jul 30, 2015 | Jul 30, 2015 |
| DEF 14A | Proxy statement | Jun 4, 2015 | Jul 16, 2015 |
| DEF 14A | Proxy statement | Apr 18, 2014 | May 30, 2014 |
| PRE 14A | Preliminary proxy statement | Apr 1, 2014 | May 30, 2014 |
| DEF 14C | Information statement | Nov 27, 2013 | Nov 27, 2013 |
| PRE 14C | Preliminary information statement | Nov 4, 2013 | Nov 4, 2013 |
| DEF 14A | Proxy statement | Apr 29, 2013 | Jun 6, 2013 |
| DEF 14A | Proxy statement | Sep 17, 2012 | Oct 23, 2012 |
| DEF 14A | Proxy statement | Jul 25, 2011 | Aug 29, 2011 |
| PRE 14A | Preliminary proxy statement | Jun 30, 2011 | Aug 29, 2011 |
| DEF 14A | Proxy statement | Jul 21, 2010 | Aug 25, 2010 |
| PRE 14A | Preliminary proxy statement | Jun 29, 2010 | Aug 25, 2010 |
| DEF 14A | Proxy statement | Sep 30, 2009 | Oct 28, 2009 |
| PRE 14A | Preliminary proxy statement | Sep 10, 2009 | Oct 28, 2009 |
| DEF 14A | Proxy statement | Mar 18, 2008 | Apr 8, 2008 |
Showing 53 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OGEN (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- FL
- Headquarters
- Lakewood Ranch, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1174940
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.